does anyone like mcu/mph?
There are a number of investors on this board who like MCU. I haven't seen any negative comments regarding the clinical studies to date. I wish someone could find something negative to say about the company so I could understand why more people aren't interested.
If MC-1 is proven to provide the cardioprotective effects found in the Phase II studies then it should be huge. No drug is going to prevent some of the deaths post CABG, but if MC-1 can decrease the infarct size or ischemic damage then its huge.
The market potential is huge. CABG, heart caths, combination drugs for HTN, plavix, statins, etc. The drug could be given to every patient exhibiting chest pain. O2, morphine, aspirin, and an MC-1.